Inactivating RNF43 or ZNRF3 mutations result in increased Wnt receptor levels in mammalian cells and promote the growth of numerous human cancers, including colorectal, endometrial, ovarian, pancreatic, gastric, and adrenocortical carcinomas1,65. Here, RNF43 is linked to cancer.